Literature DB >> 8066506

Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis.

T F Hack1, L F Degner, D G Dyck.   

Abstract

This study examined relationships between cancer patients' preferences for involvement in making treatment decisions and preferences for information about diagnosis, treatment, side effects, and prognosis. Participants were 35 women with stage I and II breast cancer recruited from two medical oncology and radiation oncology clinics. Following administration of card sort measures of preference for involvement in treatment decision making and information needs, a semi-structured interview was conducted to provide patients with an opportunity to elaborate on their role preferences and health care experiences. Results showed that patients who desired an active role in treatment decision making also desired detailed information. This relationship was not as clear for passive patients. Relative to passive patients, active patients desired significantly more detailed explanations of their diagnosis, treatment alternatives, and treatment procedures. Active patients also preferred that their physicians use the words 'cancer' or 'malignancy' when referring to their illness while passive patients preferred that their physicians use a eupheumism. Further research is needed to critically detail the advantages and disadvantages of the active and passive roles and their impact on disease progression and psychological well-being.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1994        PMID: 8066506     DOI: 10.1016/0277-9536(94)90336-0

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  53 in total

1.  Editorial: special conference issue.

Authors:  Cathy Charles; Amiram Gafni; Tim Whelan
Journal:  Health Expect       Date:  2000-03       Impact factor: 3.377

2.  Personal values and cancer treatment refusal.

Authors:  M Huijer; E van Leeuwen
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

3.  A role for the sick role. Patient preferences regarding information and participation in clinical decision-making.

Authors:  A M Stiggelbout; G M Kiebert
Journal:  CMAJ       Date:  1997-08-15       Impact factor: 8.262

4.  Information and support for women following the primary treatment of breast cancer.

Authors:  Jane C A Raupach; Janet E Hiller
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

5.  Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results.

Authors:  Heather M Davey; Alexandra L Barratt; Elizabeth Davey; Phyllis N Butow; Sally Redman; Nehmat Houssami; Glenn P Salkeld
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

Review 6.  Informed consent for clinical treatment.

Authors:  Daniel E Hall; Allan V Prochazka; Aaron S Fink
Journal:  CMAJ       Date:  2012-03-05       Impact factor: 8.262

Review 7.  Management of primary breast cancer.

Authors:  A Melville; A Liberati; R Grilli; T Sheldon
Journal:  Qual Health Care       Date:  1996-12

8.  Patient Experiences Using an Inpatient Personal Health Record.

Authors:  Janet Woollen; Jennifer Prey; Lauren Wilcox; Alexander Sackeim; Susan Restaino; Syed T Raza; Suzanne Bakken; Steven Feiner; George Hripcsak; David Vawdrey
Journal:  Appl Clin Inform       Date:  2016-06-01       Impact factor: 2.342

9.  Views of treatment decision making from adolescents with chronic illnesses and their parents: a pilot study.

Authors:  Jennifer M Knopf; Richard W Hornung; Gail B Slap; Robert F DeVellis; Maria T Britto
Journal:  Health Expect       Date:  2008-12       Impact factor: 3.377

10.  Barriers to information provision regarding breast cancer and its treatment.

Authors:  Heather J Campbell-Enns; Roberta L Woodgate; Harvey M Chochinov
Journal:  Support Care Cancer       Date:  2017-04-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.